Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented and cured, treatments are smarter and less invasive—and solutions are personal.
Johnson & Johnson Innovative Medicine is leading where medicine is going. Patients inform and inspire our science-based innovations, which continue to change and save lives. With rigorous science and compassion, we confidently address the most complex diseases of our time and unlock the potential medicines of tomorrow. Therapeutic areas include: Oncology, Immunology, Neuroscience, Cardiovascular, Pulmonary Hypertension, and Retina.
Johnson & Johnson MedTech innovates at the intersection of biology and technology. With a focus on treating with pinpoint precision in the hardest-to-reach parts of the body, restoring anatomy and reimagining healing, our portfolio of smarter, less invasive, more personalized treatments is addressing the most complex diseases. Focus areas include: Interventional Solutions, Orthopaedics, Surgery and Vision.
Solving the toughest health challenges
Every year, roughly 80,000 Americans receive a bladder cancer diagnosis. Many endure difficult and burdensome treatments in an attempt to fight the disease. But new innovations just might change that.
Caring & giving
Caring & giving
Lee-Anne James is a Janssen clinical research manager whose home base is Australia. That is, when she and her family aren’t donating their time to Mercy Ships to help treat people who lack access to lifesaving healthcare.
More than 37.5 million people worldwide are affected by this common type of heart arrhythmia—and by 2025, the number of cases will increase by 60%. For World Heart Day, learn the facts behind this heart condition, plus one patient’s diagnosis story.
Learn how new technology from Johnson & Johnson aims to be a game-changer not only for patients, but for surgeons, too.
For Healthy Vision Month, learn about one employee’s very personal mission to help restore vision for people who undergo cataract surgery.
Check out this infographic breakdown of the company’s third-quarter 2023 performance, with key highlights from its Innovative Medicine and MedTech businesses.
Johnson & Johnson has been dedicated to developing innovative treatments for blood cancers for nearly 20 years. Scientist Kodandaram “Ram” Pillarisetti is at the forefront of the company’s commitment to working toward its goal of one day eliminating the disease.
With a unique disposable camera the size of a pinkie finger, Eric Buehlmann and his team pioneered a better—and easier—way for doctors to perform back procedures.
They share similar symptoms, sure. But these three distinct conditions have distinct causes, occur in people of varying ages and have their own treatments. Read on for the key differences.
For the last 10 years, Johnson & Johnson Innovation has been on a mission to accelerate early-stage innovation aimed at advancing healthcare. As digital technology external innovation lead, Varun Ramdevan looks for the best ideas—and helps make them a reality.
For World Lung Cancer Day, learn about one patient’s journey toward getting an accurate diagnosis—and why it’s crucial to always advocate for your health.
Advancing drug discovery. Helping treatments reach patients faster. Diversifying clinical trials. Here’s a look at how Johnson & Johnson is harnessing AI to help create a healthier world.
A condition called fetal and neonatal alloimmune thrombocytopenia (FNAIT) can be deadly in newborns. That’s why Johnson & Johnson is passionate about developing a treatment for the disorder.
The key to slowing cognitive decline is diagnosing the disease as early as possible. And that’s exactly what Johnson & Johnson scientists are relentlessly pursuing.
Improvements in joint replacement techniques and technology have increased the effectiveness of this common procedure—yet some hip replacements still require a revision. Learn the latest about the surgery, plus how Johnson & Johnson is innovating to change this stat.